Abstract
The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities with the greatest success rate according to patient characteristics, AVM architecture, and the capabilities of the treatment option to fulfill the goals of treatment. Although there is a lack of data from randomized trials to guide AVM management, microsurgery is a mainstay of therapy in patients receiving definitive intervention. In this paper, we review current guidelines for surgical planning, risk-benefit analysis, and prediction of outcome in AVM patients.
| Original language | English |
|---|---|
| Pages (from-to) | 376-386 |
| Number of pages | 11 |
| Journal | British Journal of Neurosurgery |
| Volume | 23 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 1 2009 |
| Externally published | Yes |
Fingerprint
Keywords
- Arteriovenous malformation
- Complication
- Embolization
- Outcome
- Surgery
ASJC Scopus subject areas
- Clinical Neurology
- Surgery
Cite this
Treatment guidelines for cerebral arteriovenous malformation microsurgery. / Starke, Robert M.; Komotar, Ricardo J; Hwang, Brian Y.; Fischer, Laura E.; Garrett, Matthew C.; Otten, Marc L.; Connolly, E. Sander.
In: British Journal of Neurosurgery, Vol. 23, No. 4, 01.08.2009, p. 376-386.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment guidelines for cerebral arteriovenous malformation microsurgery
AU - Starke, Robert M.
AU - Komotar, Ricardo J
AU - Hwang, Brian Y.
AU - Fischer, Laura E.
AU - Garrett, Matthew C.
AU - Otten, Marc L.
AU - Connolly, E. Sander
PY - 2009/8/1
Y1 - 2009/8/1
N2 - The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities with the greatest success rate according to patient characteristics, AVM architecture, and the capabilities of the treatment option to fulfill the goals of treatment. Although there is a lack of data from randomized trials to guide AVM management, microsurgery is a mainstay of therapy in patients receiving definitive intervention. In this paper, we review current guidelines for surgical planning, risk-benefit analysis, and prediction of outcome in AVM patients.
AB - The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities with the greatest success rate according to patient characteristics, AVM architecture, and the capabilities of the treatment option to fulfill the goals of treatment. Although there is a lack of data from randomized trials to guide AVM management, microsurgery is a mainstay of therapy in patients receiving definitive intervention. In this paper, we review current guidelines for surgical planning, risk-benefit analysis, and prediction of outcome in AVM patients.
KW - Arteriovenous malformation
KW - Complication
KW - Embolization
KW - Outcome
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=68849120601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68849120601&partnerID=8YFLogxK
U2 - 10.1080/02688690902977662
DO - 10.1080/02688690902977662
M3 - Article
C2 - 19637008
AN - SCOPUS:68849120601
VL - 23
SP - 376
EP - 386
JO - British Journal of Neurosurgery
JF - British Journal of Neurosurgery
SN - 0268-8697
IS - 4
ER -